Establishment of the First Comprehensive Adult and Pediatric Hematopoietic Stem Cell Transplant Unit in the United Arab Emirates: Rising to the Challenge

Autor: Humaid O. Al-Shamsi, Amin Abyad, Panayotis Kaloyannidis, Amro El-Saddik, Ahmad Alrustamani, Ibrahim Abu Gheida, Azzam Ziade, Norbert W. Dreier, Urfan Ul-Haq, Thanda Lucy Ann Joshua, Abdul Rahman El Kinge, Ritika Coelho, Dima Ibrahim, Mehdi Afrit, Bilal Al-Lababidi, Zainul Aabideen, Mayur Sabhani, Rakeshkumar Shah, Ghaith Makhlouf, Lana Iskandaerani, Faryal Iqbal, Shiny Narayanan, Mohammed Ameen, Theresa Morrison, Charbel Khalil, Kayane Mheidly

Publikováno v: Clinics and Practice, Vol 12, Iss 1, Pp 84-90 (2022)

Hematopoietic stem cell transplantation (HSCT) is increasingly indicated for various malignant and non-malignant diseases. In the United Arab Emirates (UAE), patients that could benefit from the procedure commonly need to seek medical care abroad in

Externí odkaz: https://doaj.org/article/e9cd034fb8404d1b84e221307260ba65

Establishment of the First Comprehensive Adult and Pediatric Hematopoietic Stem Cell Transplant Unit in the United Arab Emirates: Rising to the Challenge

Autor: Humaid O. Al-Shamsi, Amin Abyad, Panayotis Kaloyannidis, Amro El-Saddik, Ahmad Alrustamani, Ibrahim Abu Gheida, Azzam Ziade, Norbert W. Dreier, Urfan Ul-Haq, Thanda Lucy Ann Joshua, Abdul Rahman El Kinge, Ritika Coelho, Dima Ibrahim, Mehdi Afrit, Bilal Al-Lababidi, Zainul Aabideen, Mayur Sabhani, Rakeshkumar Shah, Ghaith Makhlouf, Lana Iskandaerani, Faryal Iqbal, Shiny Narayanan, Mohammed Ameen, Theresa Morrison, Charbel Khalil, Kayane Mheidly

Publikováno v: Clinics and practice. 12(1)

Hematopoietic stem cell transplantation (HSCT) is increasingly indicated for various malignant and non-malignant diseases. In the United Arab Emirates (UAE), patients that could benefit from the procedure commonly need to seek medical care abroad in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af7b6172209c86e4905a3d5f53d4ec3a
https://pubmed.ncbi.nlm.nih.gov/35200262

The clinical impact of using complex molecular profiling strategies in routine oncology practice

Autor: Carlos Camps, Ramon De Las Penas, Ana Finzel, Carlos Regonesi, Helen Sadik, Gregori Ghitti, Timo Joensuu, Omalkhair Abulkhair, Anthony Kong, Philippe Aftimos, Jean-François Laes, Abdul Rahman El Kinge, Kefah Mokbel, Ibrahim Wahid, Christos Mikropoulos, Louis Kathan, K.M. Galal, Joaquim Bellmunt, Jesús García-Foncillas, Hady Ghanem, Rika Pienaar, Jean-Loup Mouysset, Fadi El Karak, Angel Garcia, James Mackay, Philippe Barthélémy, Timothy J. Perren, Guy Berchem, Petteri Hervonen, Sergey Odarchenko, Shadi S. Alkhayyat

Publikováno v: Oncotarget
r-FHPC. Repositorio Institucional de Producción Científica de la Fundación del Hospital Provincial de Castellón
instname
Oncotarget, 9 (29
r-FIHGUV. Repositorio Institucional de Producción Científica de la Fundación de Investigación del Hospital General de Valencia

Molecular profiling and functional assessment of signalling pathways of advanced solid tumours are becoming increasingly available. However, their clinical utility in guiding patients' treatment remains unknown. Here, we assessed whether molecular pr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51a1b1bcd1c52c6f16f7fe50bd7ca7b8
http://hdl.handle.net/10230/41925

Incidence of adverse drug events in public and private hospitals in Riyadh, Saudi Arabia: the (ADESA) prospective cohort study

Autor: Mashael K. Alshaikh, Abdulmajid Arwadi, Ahmed Y. Mayet, Esraa Al Tawil, Mansour Adam Mahmoud, Razia Sultana, Maha Alyahya, David W. Bates, Hisham Aljadhey, Nora A. Kalagi, Salah Zouein, Y.A. Ahmed, Sulafah Al-Shanawani, Michael D. Murray, Abdul Rahman El Kinge

Publikováno v: BMJ Open

Objectives To determine the incidence of adverse drug events (ADEs) and assess their severity and preventability in four Saudi hospitals. Design Prospective cohort study. Setting The study included patients admitted to medical, surgical and intensive

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9aebb02df5d5c5afb2dfc78ab6a9972b
https://pubmed.ncbi.nlm.nih.gov/27406640

Recombinant activated factor VII for intractable bleeding post splenectomy in a patient with myeloproliferative disorder

Autor: Ali T. Taher, Ali Shamseddine, Abdul Rahman El Kinge, Rami Mahfouz

Publikováno v: Blood Coagulation & Fibrinolysis. 18:577-579

Recombinant activated factor VII has been Food and Drug Administration approved to treat hemorrhages in hemophiliac patients with inhibitors and in acquired hemophilia patients. Recombinant activated factor VII use has also been considered for the ma

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf6f549e5e72c004f75b6577dc8f41e1
https://doi.org/10.1097/mbc.0b013e3281eec9a1